BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28370694)

  • 1. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
    Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
    Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
    Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study.
    Yang X; Wang R; Yuan X; Yao S; Wang C; Cheng J
    Radiat Oncol; 2022 Dec; 17(1):208. PubMed ID: 36539787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results.
    Niwa M; Ishikura S; Tatekawa K; Takama N; Miyakawa A; Kubota T; Kato E; Shibamoto Y
    Radiat Oncol; 2020 Jan; 15(1):25. PubMed ID: 32000814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
    Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
    Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
    Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
    Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
    Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
    Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
    Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
    Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the utility of lower dose radiotherapy for localised primary ocular adnexal MALT lymphoma.
    Leeson S; Jayamohan J; Vu H; Sundaresan P
    J Med Radiat Sci; 2021 Sep; 68(3):269-273. PubMed ID: 33675287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
    Fukutsu K; Kase S; Ishijima K; Kinoshita R; Ishida S
    Radiat Oncol; 2018 May; 13(1):95. PubMed ID: 29769097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
    Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
    Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.
    Lim SH; Kang M; Son J
    Indian J Ophthalmol; 2011; 59(4):273-7. PubMed ID: 21666310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.
    Dhakal B; Fenske TS; Ramalingam S; Shuff J; Epperla N; Hosking P; Rein L; Banerjee A; Hari P; D'Souza A; Shah N; Siker M; Griepentrog GJ; Harris GJ; Wells TS; Erickson BA; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):305-311.e2. PubMed ID: 28284742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
    Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
    Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma--Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System.
    Ohga S; Nakamura K; Shioyama Y; Sasaki T; Yamaguchi T; Yoshitake T; Terashima K; Asai K; Matsumoto K; Honda H
    Anticancer Res; 2015 Jun; 35(6):3591-7. PubMed ID: 26026132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.